These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33608826)

  • 1. Role of Liver Growth Factor (LGF) in Parkinson's Disease: Molecular Insights and Therapeutic Opportunities.
    Angelopoulou E; Paudel YN; Piperi C
    Mol Neurobiol; 2021 Jul; 58(7):3031-3042. PubMed ID: 33608826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease.
    Gonzalo-Gobernado R; Calatrava-Ferreras L; Reimers D; Herranz AS; Rodríguez-Serrano M; Miranda C; Jiménez-Escrig A; Díaz-Gil JJ; Bazán E
    PLoS One; 2013; 8(7):e67771. PubMed ID: 23861803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver growth factor promotes the survival of grafted neural stem cells in a rat model of Parkinson's disease.
    Reimers D; Osuna C; Gonzalo-Gobernado R; Herranz AS; Diaz-Gil JJ; Jimenez-Escrig A; Asensio MJ; Miranda C; Rodriguez-Serrano M; Bazan E
    Curr Stem Cell Res Ther; 2012 Jan; 7(1):15-25. PubMed ID: 21190529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease.
    Gonzalo-Gobernado R; Reimers D; Casarejos MJ; Calatrava Ferreras L; Vallejo-Muñoz M; Jiménez-Escrig A; Diaz-Gil JJ; Ulzurrun de Asanza GM; Bazán E
    Brain Sci; 2020 May; 10(5):. PubMed ID: 32455921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial cell line-derived neurotrophic factor receptor Rearranged during transfection agonist supports dopamine neurons in Vitro and enhances dopamine release In Vivo.
    Mahato AK; Kopra J; Renko JM; Visnapuu T; Korhonen I; Pulkkinen N; Bespalov MM; Domanskyi A; Ronken E; Piepponen TP; Voutilainen MH; Tuominen RK; Karelson M; Sidorova YA; Saarma M
    Mov Disord; 2020 Feb; 35(2):245-255. PubMed ID: 31840869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective Effects of Antidepressants via Upregulation of Neurotrophic Factors in the MPTP Model of Parkinson's Disease.
    Shadfar S; Kim YG; Katila N; Neupane S; Ojha U; Bhurtel S; Srivastav S; Jeong GS; Park PH; Hong JT; Choi DY
    Mol Neurobiol; 2018 Jan; 55(1):554-566. PubMed ID: 27975170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein.
    Goulding SR; Sullivan AM; O'Keeffe GW; Collins LM
    Parkinsonism Relat Disord; 2019 Jul; 64():194-201. PubMed ID: 31000327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
    Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
    Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
    Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current disease modifying approaches to treat Parkinson's disease.
    Lindholm D; Mäkelä J; Di Liberto V; Mudò G; Belluardo N; Eriksson O; Saarma M
    Cell Mol Life Sci; 2016 Apr; 73(7):1365-79. PubMed ID: 26616211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
    Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
    J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver growth factor as a tissue regenerating factor in neurodegenerative diseases.
    Gonzalo-Gobernado R; Calatrava-Ferreras L; Perucho J; Reimers D; Casarejos MJ; Herranz AS; Jimenez-Escrig A; Diaz-Gil JJ; Bazan E
    Recent Pat CNS Drug Discov; 2014; 9(3):173-80. PubMed ID: 25537484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Growth Factor "LGF" as a Therapeutic Agent for Alzheimer's Disease.
    Gonzalo-Gobernado R; Perucho J; Vallejo-Muñoz M; Casarejos MJ; Reimers D; Jiménez-Escrig A; Gómez A; Ulzurrun de Asanza GM; Bazán E
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
    Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
    Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the ATF2/CREB-PGC-1α pathway by metformin leads to dopaminergic neuroprotection.
    Kang H; Khang R; Ham S; Jeong GR; Kim H; Jo M; Lee BD; Lee YI; Jo A; Park C; Kim H; Seo J; Paek SH; Lee YS; Choi JY; Lee Y; Shin JH
    Oncotarget; 2017 Jul; 8(30):48603-48618. PubMed ID: 28611284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcranial alternating current stimulation rescues motor deficits in a mouse model of Parkinson's disease via the production of glial cell line-derived neurotrophic factor.
    Lee HJ; Jung DH; Jung YJ; Shin HK; Choi BT
    Brain Stimul; 2022; 15(3):645-653. PubMed ID: 35429660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.